ORI Names New Director

Neuroscientist Kathryn Partin will lead the US Office of Research Integrity.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

IMAGE: COLORADO STATE UNIVERSITYMore than a year and a half after its last director resigned, the Department of Health and Human Service’s (HHS) Office of Research Integrity (ORI) is getting a new leader, according to The Report on Research Compliance, which broke the news last week (December 3). The ORI, which is tasked with investigating and punishing federal grantees who engage in scientific misconduct, has tapped Colorado State University neuroscientist Kathryn Partin as its next head starting the week of December 27. The ORI’s last director, David Wright, stepped down in March 2014 after two years of dealing with what he called “dysfunctional HHS bureaucracy” in his resignation letter.

Partin, whose research involves glutamate receptors in the brain, also brings administrative experience to ORI’s top job. She has served for several years as assistant vice president for research and director of the research integrity office at Colorado State. “I look forward to this amazing opportunity,” Partin wrote in an email to ScienceInsider.

Leading ORI amid complaints from the research community that the agency is too slow to act and too light on penalizing grantees charged with misconduct will be no mean feat for Partin. Nicholas Steneck, a science historian at the University of Michigan, told ScienceInsider that, although he doesn’t know Partin personally, he hopes she’ll be game to take a close look at how ORI goes about discovering and punishing misconduct. “We developed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies